Newhall Charles W Iii - Net Worth and Insider Trading

Newhall Charles W Iii Net Worth

The estimated net worth of Newhall Charles W Iii is at least $979 Million dollars as of 2024-04-28. Newhall Charles W Iii is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 24,538,379 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $783 Million. Newhall Charles W Iii is the 10% Owner of Echo Global Logistics Inc and owns about 2,420,219 shares of Echo Global Logistics Inc (ECHO) stock worth over $117 Million. Newhall Charles W Iii is also the 10% Owner of Amicus Therapeutics Inc and owns about 5,650,340 shares of Amicus Therapeutics Inc (FOLD) stock worth over $58 Million. Besides these, Newhall Charles W Iii also holds InnerWorkings Inc (INWK) , Supernus Pharmaceuticals Inc (SUPN) , Catalyst Biosciences Inc (CBIO) , Novation Companies Inc (NOVCQ) . Details can be seen in Newhall Charles W Iii's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Newhall Charles W Iii has not made any transactions after 2023-11-16 and currently still holds the listed stock(s).

Transaction Summary of Newhall Charles W Iii

To

Newhall Charles W Iii Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Newhall Charles W Iii owns 21 companies in total, including Supernus Pharmaceuticals Inc (SUPN) , Vitae Pharmaceuticals Inc (VTAE) , and Workday Inc (WDAY) among others .

Click here to see the complete history of Newhall Charles W Iii’s form 4 insider trades.

Insider Ownership Summary of Newhall Charles W Iii

Ticker Comapny Transaction Date Type of Owner
SUPN Supernus Pharmaceuticals Inc 2023-11-16 director
VTAE Vitae Pharmaceuticals Inc 2015-07-01 director
WDAY Workday Inc 2012-10-11 10 percent owner
WWHC W World Corp 2012-07-02 director & 10 percent owner
INWK InnerWorkings Inc 2012-03-28 10 percent owner
FOLD Amicus Therapeutics Inc 2012-03-07 10 percent owner
ECHO Echo Global Logistics Inc 2009-10-01 10 percent owner
GRPN Groupon Inc 2011-11-03 10 percent owner
GLUU Glu Mobile Inc 2011-08-08 10 percent owner
WIFI Boingo Wireless Inc 2011-05-03 10 percent owner
VG Vonage Holdings Corp 2006-05-23 10 percent owner
ARYX ARYx Therapeutics Inc 2011-03-10 10 percent owner
FNGN Financial Engines Inc 2010-08-30 10 percent owner
SNSS Sunesis Pharmaceuticals Inc 2010-06-30 10 percent owner
VLTC Voltari Corp 2010-06-23 10 percent owner
IQNT Inteliquent Inc 2009-02-20 10 percent owner
PRTK Paratek Pharmaceuticals Inc 2006-05-09 10 percent owner
DZSI DZS Inc 2007-08-14 10 percent owner
CBIO Catalyst Biosciences Inc 2006-04-12 10 percent owner
ARDMQ Aradigm Corp 2004-02-20 10 percent owner
VIRX Viracta Therapeutics Inc 2009-04-03 10 percent owner

Newhall Charles W Iii Latest Holdings Summary

Newhall Charles W Iii currently owns a total of 7 stocks. Among these stocks, Newhall Charles W Iii owns 24,538,379 shares of iShares Indl/Office Real Estate Capped (FNIO) as of November 28, 2011, with a value of $783 Million and a weighting of 79.94%. Newhall Charles W Iii owns 2,420,219 shares of Echo Global Logistics Inc (ECHO) as of October 1, 2009, with a value of $117 Million and a weighting of 11.93%. Newhall Charles W Iii also owns 5,650,340 shares of Amicus Therapeutics Inc (FOLD) as of March 7, 2012, with a value of $58 Million and a weighting of 5.93%. The other 4 stocks InnerWorkings Inc (INWK) , Supernus Pharmaceuticals Inc (SUPN) , Catalyst Biosciences Inc (CBIO) , Novation Companies Inc (NOVCQ) have a combined weighting of 2.2% among all his current holdings.

Latest Holdings of Newhall Charles W Iii

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FNIO iShares Indl/Office Real Estate Capped 2011-11-28 24,538,379 31.89 782,528,906
ECHO Echo Global Logistics Inc 2009-10-01 2,420,219 48.24 116,751,365
FOLD Amicus Therapeutics Inc 2012-03-07 5,650,340 10.28 58,085,495
INWK InnerWorkings Inc 2012-02-29 6,029,190 2.99 18,027,278
SUPN Supernus Pharmaceuticals Inc 2023-11-16 117,089 30.07 3,520,866
CBIO Catalyst Biosciences Inc 2006-04-12 3,343 7.67 25,639
NOVCQ Novation Companies Inc 2006-05-15 1,225,179 0.00 123

Holding Weightings of Newhall Charles W Iii


Newhall Charles W Iii Form 4 Trading Tracker

According to the SEC Form 4 filings, Newhall Charles W Iii has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 1,291,493 shares on November 28, 2011, which brought Newhall Charles W Iii around $41 Million.

According to the SEC Form 4 filings, Newhall Charles W Iii has made a total of 0 transactions in Echo Global Logistics Inc (ECHO) over the past 5 years. The most-recent trade in Echo Global Logistics Inc is the sale of 0 shares on October 1, 2009, which brought Newhall Charles W Iii around $0.

According to the SEC Form 4 filings, Newhall Charles W Iii has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the acquisition of 1,140,000 shares on March 7, 2012, which cost Newhall Charles W Iii around $6 Million.

More details on Newhall Charles W Iii's insider transactions can be found in the Insider Trading History of Newhall Charles W Iii table.

Insider Trading History of Newhall Charles W Iii

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Newhall Charles W Iii Trading Performance

GuruFocus tracks the stock performance after each of Newhall Charles W Iii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Newhall Charles W Iii is 13.21%. GuruFocus also compares Newhall Charles W Iii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Newhall Charles W Iii within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Newhall Charles W Iii's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Newhall Charles W Iii

Average Return

-35.17%

Average return per transaction

Outperforming Transactions

25%

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.54 13.21 12.67 -35.17 -28.88 -14.79
Relative Return to S&P 500(%) -10.04 14.25 6.85 -50.29 -39.3 -16.33

Newhall Charles W Iii Ownership Network

Ownership Network List of Newhall Charles W Iii

No Data

Ownership Network Relation of Newhall Charles W Iii


Newhall Charles W Iii Owned Company Details

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Newhall Charles W Iii is the director of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Newhall Charles W Iii made 1 insider transaction in Supernus Pharmaceuticals Inc (SUPN) with a net sale of 2,500. Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 116,005 shares made by Padmanabh P. Bhatt , a net sale of 76,390 shares made by Jack A. Khattar , and a net sale of 21,235 shares made by Tami Tillotson Martin .

In summary, during the past 3 months, insiders sold 98,505 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 98,505 shares. During the past 18 months, 231,113 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,113 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

Newhall Charles W Iii Mailing Address

Above is the net worth, insider trading, and ownership report for Newhall Charles W Iii. You might contact Newhall Charles W Iii via mailing address: 1119 St Paul St, Baltimore Md 21202.

Discussions on Newhall Charles W Iii

No discussions yet.